Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124696372 | 12469637 | 2 | F | 20160609 | 20160615 | 20160926 | EXP | US-ALEXION PHARMACEUTICALS INC-A201604348 | ALEXION | 0.00 | M | Y | 0.00000 | 20160926 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124696372 | 12469637 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | UNK | U | T3-AE5434B02 | 125166 | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||
124696372 | 12469637 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | U | 125166 | CONCENTRATE FOR SOLUTION FOR INFUSION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124696372 | 12469637 | 1 | Chronic lymphocytic leukaemia |
124696372 | 12469637 | 2 | Off label use |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124696372 | 12469637 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124696372 | 12469637 | Haemoglobin decreased | |
124696372 | 12469637 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |